Name | Number of supported studies | Average coverage | |
---|---|---|---|
CD4-positive, alpha-beta T cell | 3 studies | 16% ± 0% | |
fibroblast | 3 studies | 17% ± 1% |
Insufficient scRNA-seq data for expression of GALT at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 1537.22 | 1445 / 1445 | 100% | 6.60 | 183 / 183 |
prostate | 100% | 2636.01 | 245 / 245 | 100% | 12.41 | 502 / 502 |
stomach | 100% | 1537.29 | 359 / 359 | 100% | 8.22 | 286 / 286 |
thymus | 100% | 3040.47 | 653 / 653 | 100% | 13.95 | 605 / 605 |
bladder | 100% | 1679.90 | 21 / 21 | 100% | 9.94 | 503 / 504 |
uterus | 100% | 2420.82 | 170 / 170 | 100% | 9.74 | 458 / 459 |
lung | 100% | 1817.04 | 578 / 578 | 100% | 8.48 | 1152 / 1155 |
kidney | 100% | 2581.35 | 89 / 89 | 100% | 8.81 | 898 / 901 |
intestine | 100% | 2330.14 | 966 / 966 | 100% | 9.66 | 525 / 527 |
adrenal gland | 100% | 3455.61 | 258 / 258 | 100% | 17.25 | 229 / 230 |
liver | 100% | 5086.54 | 225 / 226 | 100% | 27.16 | 406 / 406 |
ovary | 100% | 2479.08 | 180 / 180 | 100% | 7.66 | 428 / 430 |
pancreas | 100% | 1065.25 | 327 / 328 | 99% | 8.94 | 177 / 178 |
brain | 99% | 1442.75 | 2625 / 2642 | 99% | 7.91 | 701 / 705 |
skin | 100% | 1777.51 | 1806 / 1809 | 99% | 10.00 | 465 / 472 |
breast | 100% | 1731.89 | 459 / 459 | 95% | 5.81 | 1063 / 1118 |
eye | 0% | 0 | 0 / 0 | 100% | 14.26 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 13.48 | 29 / 29 |
spleen | 100% | 3152.61 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 8.26 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 3.82 | 1 / 1 |
adipose | 100% | 1590.11 | 1203 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1804.94 | 1332 / 1335 | 0% | 0 | 0 / 0 |
heart | 99% | 1790.24 | 853 / 861 | 0% | 0 | 0 / 0 |
muscle | 99% | 1073.36 | 794 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 92% | 941.40 | 855 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0033499 | Biological process | galactose catabolic process via UDP-galactose |
GO_0006011 | Biological process | UDP-glucose metabolic process |
GO_0019388 | Biological process | galactose catabolic process |
GO_0006012 | Biological process | galactose metabolic process |
GO_0005829 | Cellular component | cytosol |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0005737 | Cellular component | cytoplasm |
GO_0008108 | Molecular function | UDP-glucose:hexose-1-phosphate uridylyltransferase activity |
GO_0005515 | Molecular function | protein binding |
GO_0008270 | Molecular function | zinc ion binding |
Gene name | GALT |
Protein name | Galactose-1-phosphate uridylyltransferase isoform 2 Galactose-1-phosphate uridylyltransferase Galactose-1-phosphate uridylyltransferase (Gal-1-P uridylyltransferase) (EC 2.7.7.12) (UDP-glucose--hexose-1-phosphate uridylyltransferase) Galactose-1-phosphate uridyl transferase Galactose-1-phosphate uridylyltransferase (EC 2.7.7.12) Galactose-1-phosphate uridyl transferase (EC 2.7.1.12) Galactose-1-phosphate uridyltransferase (EC 2.7.7.12) Galactose-1-phosphate uridyl transferase (EC 2.7.7.12) |
Synonyms | |
Description | FUNCTION: Plays an important role in galactose metabolism. . |
Accessions | ENST00000554897.5 Q14379 D0EM86 ENST00000554085.5 Q14367 Q9UMJ9 Q7KZ63 Q16554 E5LCI1 ENST00000450095.6 [P07902-2] P07902 C8CHJ3 Q14366 C1P5Z6 Q14354 A0A0S2Z3Y7 D0EM87 D1MBF5 ENST00000556244.1 P78433 Q14368 ENST00000378842.8 [P07902-1] A0A0S2Z4I0 G3V223 F2Z2X9 G3V3U5 F6KV90 Q14362 H0YJL3 ENST00000554550.5 Q14388 C8CHJ4 ENST00000473506.6 D1MBF6 |